BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Li SN, Yang S, Wang HQ, Hui TL, Cheng M, Zhang X, Li BK, Wang GY. Upregulated lncRNA PRNT promotes progression and oxaliplatin resistance of colorectal cancer cells by regulating HIPK2 transcription. World J Gastrointest Oncol 2024; 16(4): 1564-1577 [PMID: 38660648 DOI: 10.4251/wjgo.v16.i4.1564]
URL: https://www.wjgnet.com/1948-5204/full/v16/i4/1564.htm
Number Citing Articles
1
Alessandra Verdina, Alessia Garufi, Valerio D’Orazi, Gabriella D’Orazi. HIPK2 in Colon Cancer: A Potential Biomarker for Tumor Progression and Response to TherapiesInternational Journal of Molecular Sciences 2024; 25(14): 7678 doi: 10.3390/ijms25147678
2
Jia-Mei Yu, Chong-Qi Sun, Huan-Huan Xu, Ya-Li Jiang, Xing-Yu Jiang, Si-Qi Ni, Ting-Yu Zhao, Ling-Xiang Liu. Navigating the labyrinth of long non-coding RNAs in colorectal cancer: From chemoresistance to autophagyWorld Journal of Gastrointestinal Oncology 2024; 16(8): 3376-3381 doi: 10.4251/wjgo.v16.i8.3376
3
Daosong Dong, Xue Yu, Jingjing Xu, Na Yu, Zhe Liu, Yanbin Sun. Cellular and molecular mechanisms of gastrointestinal cancer liver metastases and drug resistanceDrug Resistance Updates 2024; 77: 101125 doi: 10.1016/j.drup.2024.101125